Xiu Nie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xiu Nie has a total of 284 co-authors. Here are the top co-authors by number of shared publications:
- Xiaona Chang
Department of Pathology Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan Hubei China
45 shared publications - Denglong Cheng
Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
44 shared publications - Falong Zou
Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
44 shared publications - Fuwei Mao
Department of Gastrointestinal Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
44 shared publications - Jia Yang
Department of Gastrointestinal Surgery, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
44 shared publications - Jianguo Shi
Department of Gastrointestinal Surgery, The Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
44 shared publications
Latest Publications
- Open Access
- 27 October 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (21) , 3525
Comprehensive Analysis of Next-Generation Sequencing and ARMS-PCR for Detecting EGFR S768 Mutations in Chinese Non-Small Cell Lung Cancer Patients
Background: Accurate detection of mutations at the EGFR S768 site is crucial for selecting appropriate treatment regimens for patients with non-small cell lung cancer (NSCLC). This study compared Next-Generation Sequencing (NGS) and amplification refractory mutation system polymerase chain reaction (ARMS-PCR) for detecting EGFR S768 mutations in Chinese NSCLC patients. Methods: This study retrospectively analyzed 20,731 molecular pathology tests (8345 by NGS and 12,386 by ARMS-PCR). Results: The detection rate of EGFR S768 variants was significantly lower by ARMS-PCR than by NGS (0.40% vs. 1.15%, p < 0.001). The variants detected by ARMS-PCR were predominantly S768I, whereas NGS identified a broader spectrum, including S768I, S768_D770dup, S768_V769delinsIL, and S768_V769insLDS. Furthermore, the EGFR S768I mutation frequently co-occurred with other EGFR mutations, while insertion mutations at or near the EGFR S768 site rarely coexisted with other EGFR mutations (95.08% vs. 3.03%, p < 0.001). Notably, three cases with S768_V769delinsIL or V769_D770insSVV detected by NGS were identified as S768I by ARMS-PCR, which potentially affected the selection of patients’ treatment plans. The sequence variations such as c.2307_2308insAGCGTGGTG, c.2303_2305delinsTCT, and c.2303_2305delinsTTT may be the reasons for the inconsistency between ARMS-PCR and NGS, due to possible non-specific primer binding. However, this remains a hypothesis based on sequence comparison and requires further experimental validation. Conclusions: Complex mutations or insertions around EGFR S768 site may cause discordant results between ARMS-PCR and NGS. NGS was recommended to confirm the EGFR S768 variants when the patient experiences rapid disease progression during treatment with EGFR S768I-directed targeted therapy.
- 27 October 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (21) , 3525
Open AccessComprehensive Analysis of Next-Generation Sequencing and ARMS-PCR for Detecting EGFR S768 Mutations in Chinese Non-Small Cell Lung Cancer Patients
Background: Accurate detection of mutations at the EGFR S768 site is crucial for selecting appropriate treatment regimens for patients with non-small cell lung cancer (NSCLC). This study compared Next-Generation Sequencing (NGS) and amplification refractory mutation system polymerase chain reaction (ARMS-PCR) for detecting EGFR S768 mutations in Chinese NSCLC patients. Methods: This study retrospectively analyzed 20,731 molecular pathology tests (8345 by NGS and 12,386 by ARMS-PCR). Results: The detection rate of EGFR S768 variants was significantly lower by ARMS-PCR than by NGS (0.40% vs. 1.15%, p < 0.001). The variants detected by ARMS-PCR were predominantly S768I, whereas NGS identified a broader spectrum, including S768I, S768_D770dup, S768_V769delinsIL, and S768_V769insLDS. Furthermore, the EGFR S768I mutation frequently co-occurred with other EGFR mutations, while insertion mutations at or near the EGFR S768 site rarely coexisted with other EGFR mutations (95.08% vs. 3.03%, p < 0.001). Notably, three cases with S768_V769delinsIL or V769_D770insSVV detected by NGS were identified as S768I by ARMS-PCR, which potentially affected the selection of patients’ treatment plans. The sequence variations such as c.2307_2308insAGCGTGGTG, c.2303_2305delinsTCT, and c.2303_2305delinsTTT may be the reasons for the inconsistency between ARMS-PCR and NGS, due to possible non-specific primer binding. However, this remains a hypothesis based on sequence comparison and requires further experimental validation. Conclusions: Complex mutations or insertions around EGFR S768 site may cause discordant results between ARMS-PCR and NGS. NGS was recommended to confirm the EGFR S768 variants when the patient experiences rapid disease progression during treatment with EGFR S768I-directed targeted therapy.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Table S2 from Palmitic Acid Accumulation Activates Fibroblasts and Promotes Matrix Stiffness in Colorectal Cancer
The primer sequences for RT-qPCR.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessTable S2 from Palmitic Acid Accumulation Activates Fibroblasts and Promotes Matrix Stiffness in Colorectal Cancer
The primer sequences for RT-qPCR.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Excel 1 from Palmitic Acid Accumulation Activates Fibroblasts and Promotes Matrix Stiffness in Colorectal Cancer
Differential expression analysis of the transcriptome of NF and CAF in OCRC, CRC and normal SMA positive tissues
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Excel 1 from Palmitic Acid Accumulation Activates Fibroblasts and Promotes Matrix Stiffness in Colorectal Cancer
Differential expression analysis of the transcriptome of NF and CAF in OCRC, CRC and normal SMA positive tissues
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S10 from Palmitic Acid Accumulation Activates Fibroblasts and Promotes Matrix Stiffness in Colorectal Cancer
Figure S10: PA does not directly promote NF-to-mCAF activation. (A) CCK-8 assay determining the optimal concentration of CAFs stimulated by PA. (B) CCK-8 assay analysis of the relationship between PA stimulation and CAFs proliferation. (C) Evaluation of changes in MMPs and TIMPs secretion in CAFs and NFs induced by PA. (D) qPCR assay was conducted to examine whether PA stimulation can promote gene expression of FN1, POSTN, and LUM (mCAFs maker) in CAFs. (E-F) Western blotting (E) and CCK-8 (F) assays confirmed whether PA could directly promote the activation of NFs to CAFs and facilitates NFs proliferation. (G) qPCR assay examined whether PA stimulation can promote mCAFs marker (FN1, POSTN, and LUM) gene expression. Statistical significance was determined by one-way ANOVA. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, ns, no significance.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S10 from Palmitic Acid Accumulation Activates Fibroblasts and Promotes Matrix Stiffness in Colorectal Cancer
Figure S10: PA does not directly promote NF-to-mCAF activation. (A) CCK-8 assay determining the optimal concentration of CAFs stimulated by PA. (B) CCK-8 assay analysis of the relationship between PA stimulation and CAFs proliferation. (C) Evaluation of changes in MMPs and TIMPs secretion in CAFs and NFs induced by PA. (D) qPCR assay was conducted to examine whether PA stimulation can promote gene expression of FN1, POSTN, and LUM (mCAFs maker) in CAFs. (E-F) Western blotting (E) and CCK-8 (F) assays confirmed whether PA could directly promote the activation of NFs to CAFs and facilitates NFs proliferation. (G) qPCR assay examined whether PA stimulation can promote mCAFs marker (FN1, POSTN, and LUM) gene expression. Statistical significance was determined by one-way ANOVA. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, ns, no significance.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S5 from Palmitic Acid Accumulation Activates Fibroblasts and Promotes Matrix Stiffness in Colorectal Cancer
Figure S5: OCRC and CRC differed in stromal cells, with significantly more matrix CAFs in OCRC. (A) Isolated and identified the primary CAFs from fresh OCRC and CRC tissues, red: Vimentin, green: α-SMA, (Scale bars = 100μm). (B) KEGG and GO enrichment analysis of differentially expressed genes in CAFs from OCRC and CRC tissues. (C-D) Expression levels of ECM-related matrix proteins and matrix metalloproteinases in OCRC and CRC were detected by qPCR (C) and ELSIA (D). Statistical significance was determined by unpaired Student t test. *P <0.05, **P <0.01, ***P <0.001, ****P <0.0001.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S5 from Palmitic Acid Accumulation Activates Fibroblasts and Promotes Matrix Stiffness in Colorectal Cancer
Figure S5: OCRC and CRC differed in stromal cells, with significantly more matrix CAFs in OCRC. (A) Isolated and identified the primary CAFs from fresh OCRC and CRC tissues, red: Vimentin, green: α-SMA, (Scale bars = 100μm). (B) KEGG and GO enrichment analysis of differentially expressed genes in CAFs from OCRC and CRC tissues. (C-D) Expression levels of ECM-related matrix proteins and matrix metalloproteinases in OCRC and CRC were detected by qPCR (C) and ELSIA (D). Statistical significance was determined by unpaired Student t test. *P <0.05, **P <0.01, ***P <0.001, ****P <0.0001.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S11 from Palmitic Acid Accumulation Activates Fibroblasts and Promotes Matrix Stiffness in Colorectal Cancer
Figure S11: PA promoted CAFs function and facilitated partial NF-to-mCAF activation by stimulated CRC cells. (A) CCK-8 assay to explore the optimal concentration of CRC cells stimulated by PA. (B) Oil Red O staining visualizing lipid droplet accumulation in CRC cells following 48 hours of PA stimulation (Scale bars = 50μm). (C-E) Analysis of NF-to-mCAF activation via CRC cells under PA stimulation, including CCK-8 (C) assay, qPCR (D) assay, and cellular immunofluorescence staining (E) (Scale bars = 20μm). (F) Comparison of ECM-related matrix proteins secretion between NFs activated to CAFs and CAFs directly stimulated by PA. Statistical significance was determined by one-way and two-way ANOVA. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, ns, no significance.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S11 from Palmitic Acid Accumulation Activates Fibroblasts and Promotes Matrix Stiffness in Colorectal Cancer
Figure S11: PA promoted CAFs function and facilitated partial NF-to-mCAF activation by stimulated CRC cells. (A) CCK-8 assay to explore the optimal concentration of CRC cells stimulated by PA. (B) Oil Red O staining visualizing lipid droplet accumulation in CRC cells following 48 hours of PA stimulation (Scale bars = 50μm). (C-E) Analysis of NF-to-mCAF activation via CRC cells under PA stimulation, including CCK-8 (C) assay, qPCR (D) assay, and cellular immunofluorescence staining (E) (Scale bars = 20μm). (F) Comparison of ECM-related matrix proteins secretion between NFs activated to CAFs and CAFs directly stimulated by PA. Statistical significance was determined by one-way and two-way ANOVA. *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001, ns, no significance.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S2 from Palmitic Acid Accumulation Activates Fibroblasts and Promotes Matrix Stiffness in Colorectal Cancer
Figure S2: OCRC and CRC differed substantially in ECM constitution, biomechanics, and collagen characteristics. (A) Masson staining of OCRC, CRC and normal tissues (Scale bars = 1mm, 50μm). (B) Quantification of collagen fiber content in OCRC, CRC and normal tissues by Masson staining (n=15). (C) Mean E-moduli measurements in OCRC, CRC and normal tissues (n=10). (D) Raman spectroscopy analysis of collagen fibers in OCRC and CRC tissues (n=10). (E) Immunohistochemistry staining and semi-quantitative analysis of CD44 in the ECM of OCRC and CRC tissues (n = 9, Scale bars = 1mm, 50μm). (F) Safranin O-fast green staining to assess chondroitin sulfate levels in OCRC and CRC tissues (Scale bars = 1mm, 50μm). (G) Analysis of collagen fiber alignment in OCRC and CRC ECM (n=15). (H) Raman spectroscopy analysis of collagen fiber orientation in OCRC and CRC ECM (n=10). (I) Immunohistochemical staining analysis of T cells (CD4, CD8) and macrophages (CD68) in the tumor microenvironments of OCRC and CRC (Scale bars = 1mm, 50μm). Statistical significance was determined by unpaired Student t test. *P <0.05, **P <0.01, ***P <0.001, ****P <0.0001, ns, no significance.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S2 from Palmitic Acid Accumulation Activates Fibroblasts and Promotes Matrix Stiffness in Colorectal Cancer
Figure S2: OCRC and CRC differed substantially in ECM constitution, biomechanics, and collagen characteristics. (A) Masson staining of OCRC, CRC and normal tissues (Scale bars = 1mm, 50μm). (B) Quantification of collagen fiber content in OCRC, CRC and normal tissues by Masson staining (n=15). (C) Mean E-moduli measurements in OCRC, CRC and normal tissues (n=10). (D) Raman spectroscopy analysis of collagen fibers in OCRC and CRC tissues (n=10). (E) Immunohistochemistry staining and semi-quantitative analysis of CD44 in the ECM of OCRC and CRC tissues (n = 9, Scale bars = 1mm, 50μm). (F) Safranin O-fast green staining to assess chondroitin sulfate levels in OCRC and CRC tissues (Scale bars = 1mm, 50μm). (G) Analysis of collagen fiber alignment in OCRC and CRC ECM (n=15). (H) Raman spectroscopy analysis of collagen fiber orientation in OCRC and CRC ECM (n=10). (I) Immunohistochemical staining analysis of T cells (CD4, CD8) and macrophages (CD68) in the tumor microenvironments of OCRC and CRC (Scale bars = 1mm, 50μm). Statistical significance was determined by unpaired Student t test. *P <0.05, **P <0.01, ***P <0.001, ****P <0.0001, ns, no significance.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Excel 2 from Palmitic Acid Accumulation Activates Fibroblasts and Promotes Matrix Stiffness in Colorectal Cancer
Nontargeted metabolomics analysis of OCRC and CRC tissues
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Excel 2 from Palmitic Acid Accumulation Activates Fibroblasts and Promotes Matrix Stiffness in Colorectal Cancer
Nontargeted metabolomics analysis of OCRC and CRC tissues
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S1 from Palmitic Acid Accumulation Activates Fibroblasts and Promotes Matrix Stiffness in Colorectal Cancer
Figure S1: OCRC and CRC differed substantially in clinicopathology, with poorer prognoses in OCRC. (A) Comparative analysis of OS and DFS in CRC (n=1272) and OCRC (n=198) patients. (B) Clinicopathological characteristics of CRC (n=1272) and OCRC (n=198) patients. (C) Comparative analysis of OS and DFS in 150 matched pairs of CRC and OCRC patients. (D) Clinicopathological characteristics of 150 matched pairs of OCRC and CRC. Statistical significance was determined by Chi-Squared Test. *P <0.05, **P <0.01, ***P <0.001.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S1 from Palmitic Acid Accumulation Activates Fibroblasts and Promotes Matrix Stiffness in Colorectal Cancer
Figure S1: OCRC and CRC differed substantially in clinicopathology, with poorer prognoses in OCRC. (A) Comparative analysis of OS and DFS in CRC (n=1272) and OCRC (n=198) patients. (B) Clinicopathological characteristics of CRC (n=1272) and OCRC (n=198) patients. (C) Comparative analysis of OS and DFS in 150 matched pairs of CRC and OCRC patients. (D) Clinicopathological characteristics of 150 matched pairs of OCRC and CRC. Statistical significance was determined by Chi-Squared Test. *P <0.05, **P <0.01, ***P <0.001.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Figure S4 from Palmitic Acid Accumulation Activates Fibroblasts and Promotes Matrix Stiffness in Colorectal Cancer
Figure S4: Functional analyses on α-SMA-positive CAFs and NFs from OCRC, CRC, and normal tissues. (A) KEGG and GO enrichment analysis of α-SMA positive cells from OCRC and CRC tissues. (B) KEGG and GO enrichment analysis of α-SMA positive cells from OCRC and Normal tissues. (C) KEGG and GO enrichment analysis of α-SMA positive cells from CRC and Normal tissues.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessFigure S4 from Palmitic Acid Accumulation Activates Fibroblasts and Promotes Matrix Stiffness in Colorectal Cancer
Figure S4: Functional analyses on α-SMA-positive CAFs and NFs from OCRC, CRC, and normal tissues. (A) KEGG and GO enrichment analysis of α-SMA positive cells from OCRC and CRC tissues. (B) KEGG and GO enrichment analysis of α-SMA positive cells from OCRC and Normal tissues. (C) KEGG and GO enrichment analysis of α-SMA positive cells from CRC and Normal tissues.